Loading
A phase 2 trial of dexamethasone in colorectal cancer, run by Institute of Oncology Ljubljana, now recruiting.
Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI Study) is a phase 2, randomised interventional study registered as NCT07432399 by Institute of Oncology Ljubljana, with a registry enrolment figure of 100 participants, started 2025-09-01 and due to reach its primary completion in 2027-05-01. Interventions recorded: Lidocaine; Dexamethasone; Placebo. Conditions listed: Colon Cancer; Colorectal Cancer; Perioperative Immune Response. Primary outcome: Change in Serum Cytokine Concentrations (IL-6, IL-8, IL-10, TNF-alpha). Colorectal eligibility wording from the registry: "* Histologically confirmed colon cancer". Sites: Slovenia. No results are recorded here; the registry entry is the source.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.